630 related articles for article (PubMed ID: 18538192)
1. A comprehensive approach to management of ventricular arrhythmias.
Kusumoto F
Cardiol Clin; 2008 Aug; 26(3):481-96, vii. PubMed ID: 18538192
[TBL] [Abstract][Full Text] [Related]
2. Determinants of patient survival rate after implantation of a cardioverter-defibrillator without resynchronisation capability.
Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B
Kardiol Pol; 2012; 70(11):1099-110. PubMed ID: 23180517
[TBL] [Abstract][Full Text] [Related]
3. Noninvasive arrhythmia risk stratification in idiopathic dilated cardiomyopathy: results of the Marburg Cardiomyopathy Study.
Grimm W; Christ M; Bach J; Müller HH; Maisch B
Circulation; 2003 Dec; 108(23):2883-91. PubMed ID: 14623812
[TBL] [Abstract][Full Text] [Related]
4. Implantable cardioverter-defibrillator therapy and the total burden of sudden cardiac death.
Huikuri HV
Europace; 2009 Dec; 11(12):1574. PubMed ID: 19933771
[No Abstract] [Full Text] [Related]
5. [The implantable cardioverter-defibrillator and hypertrophic cardiomyopathy. Experience at three centers].
Marín F; Gimeno JR; Payá E; García-Alberola A; Pérez-Alvarez L; Fernández X; de la Morena G; Sogorb F; Castro-Beiras A; Valdés M; Martínez JG; Monserrat L
Rev Esp Cardiol; 2006 Jun; 59(6):537-44. PubMed ID: 16790196
[TBL] [Abstract][Full Text] [Related]
6. Long-term follow-up and risk assessment of arrhythmogenic right ventricular dysplasia/cardiomyopathy: personal experience from different primary and tertiary centres.
Peters S
J Cardiovasc Med (Hagerstown); 2007 Jul; 8(7):521-6. PubMed ID: 17568286
[TBL] [Abstract][Full Text] [Related]
7. Recurrence of ventricular arrhythmias in patients with non-ischaemic dilated cardiomyopathy: evidence-based predictors.
Dułak E; Lubiński A; Bissinger A; Przybylski A; Sterlinski M; Filipecki A; Pazdyga A; Zienciuk A; Kempa M; Królak T; Szwed H; Trusz-Gluza M; Kargul W
Kardiol Pol; 2009 Aug; 67(8):837-44. PubMed ID: 19784881
[TBL] [Abstract][Full Text] [Related]
8. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy.
Kadish A; Dyer A; Daubert JP; Quigg R; Estes NA; Anderson KP; Calkins H; Hoch D; Goldberger J; Shalaby A; Sanders WE; Schaechter A; Levine JH;
N Engl J Med; 2004 May; 350(21):2151-8. PubMed ID: 15152060
[TBL] [Abstract][Full Text] [Related]
9. [Factors predisposing to the reprogramming of implantable cardioverter-defibrillators and the causes of changes in pharmacotherapy in patients with dilated cardiomyopathy for primary prevention of sudden cardiac death].
Pudło J; Liszniański P; Senderek T; Lelakowska-Pieła M; Lelakowski J; Nowak J
Pol Merkur Lekarski; 2015 Aug; 39(230):86-90. PubMed ID: 26319381
[TBL] [Abstract][Full Text] [Related]
10. Right ventricular stimulation threshold at ICD implant predicts device therapy in primary prevention patients with ischaemic heart disease.
Atary JZ; Borleffs CJ; van der Bom JG; Trines SA; Bootsma M; Zeppenfeld K; van Erven L; Schalij MJ
Europace; 2010 Nov; 12(11):1581-8. PubMed ID: 20639206
[TBL] [Abstract][Full Text] [Related]
11. Death without prior appropriate implantable cardioverter-defibrillator therapy: a competing risk study.
Koller MT; Schaer B; Wolbers M; Sticherling C; Bucher HC; Osswald S
Circulation; 2008 Apr; 117(15):1918-26. PubMed ID: 18391108
[TBL] [Abstract][Full Text] [Related]
12. Implantable cardioverter defibrillator therapy: ten years experience in a medical center.
Chen TE; Wang CC; Chang SH; Yeh SJ; Wu D
Chang Gung Med J; 2008; 31(1):81-90. PubMed ID: 18419057
[TBL] [Abstract][Full Text] [Related]
13. Obesity as a risk factor for sustained ventricular tachyarrhythmias in MADIT II patients.
Pietrasik G; Goldenberg I; McNitt S; Moss AJ; Zareba W
J Cardiovasc Electrophysiol; 2007 Feb; 18(2):181-4. PubMed ID: 17338766
[TBL] [Abstract][Full Text] [Related]
14. Application of the main implantable cardioverter-defibrillator trials and the 2006 Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death.
Proclemer A; Ghidina M
J Cardiovasc Med (Hagerstown); 2007 May; 8(5):320-3. PubMed ID: 17443096
[No Abstract] [Full Text] [Related]
15. [Implantable defibrillators--current status of guidelines. Recognized and possible indications--prerequisites].
Andresen D
Fortschr Med; 1996 Apr; 114(11):128-32. PubMed ID: 8682425
[TBL] [Abstract][Full Text] [Related]
16. [Implantable cardioverter-defibrillator in the treatment of two patients with an increased risk of sudden cardiac death].
van den Berg MP; van Tintelen JP; van Dessel PF; van Veldhuisen DJ
Ned Tijdschr Geneeskd; 2004 Oct; 148(43):2132-5. PubMed ID: 15553359
[TBL] [Abstract][Full Text] [Related]
17. Use of traditional and biventricular implantable cardiac devices for primary and secondary prevention of sudden death.
Klein MH; Gold MR
Cardiol Clin; 2008 Aug; 26(3):419-31, vi-vii. PubMed ID: 18538188
[TBL] [Abstract][Full Text] [Related]
18. Are nonsustained ventricular tachycardias predictive of major arrhythmias in patients with dilated cardiomyopathy on optimal medical treatment?
Zecchin M; Di Lenarda A; Gregori D; Merlo M; Pivetta A; Vitrella G; Sabbadini G; Mestroni L; Sinagra G
Pacing Clin Electrophysiol; 2008 Mar; 31(3):290-9. PubMed ID: 18307623
[TBL] [Abstract][Full Text] [Related]
19. Ventricular tachycardia and ventricular fibrillation.
Srivathsan K; Ng DW; Mookadam F
Expert Rev Cardiovasc Ther; 2009 Jul; 7(7):801-9. PubMed ID: 19589116
[TBL] [Abstract][Full Text] [Related]
20. Circumstances and outcomes of sudden unexpected death in patients with high-risk myocardial infarction: implications for prevention.
Ye S; Grunnert M; Thune JJ; Stephenson KM; Uno H; Finn PV; McMurray JJ; Velazquez EJ; Califf R; Pfeffer MA; Solomon SD
Circulation; 2011 Jun; 123(23):2674-80. PubMed ID: 21606398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
